According to a recent LinkedIn post from Big Health, the company is promoting a May 15, 2026 webinar aimed at healthcare providers interested in integrating digital CBT-I into their practices. The session will focus on SleepioRx, positioning it as a tool to expand access to evidence-based insomnia care and outlining clinical workflows.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The post highlights that the webinar will address current gaps in insomnia care, the evidence base behind SleepioRx, and real-world patient experience via case studies. It also notes that senior clinical leaders, including the Chief Medical Officer and VP of Clinical Affairs, will lead the discussion, which may underscore the strategic importance of the product in Big Health’s portfolio.
In addition, the content outlines practical aspects such as cost, coverage, and billing, along with multiple pathways for offering SleepioRx, including direct contracts and referral models. For investors, this emphasis on reimbursement and operational integration suggests Big Health is working to lower adoption barriers, potentially supporting broader provider uptake and recurring revenue.
The focus on educating providers about workflow fit and financial considerations could indicate an effort to deepen penetration in clinical settings rather than solely targeting employers or consumers. If successful, this strategy may enhance the scalability of SleepioRx and strengthen Big Health’s competitive position in the digital therapeutics and behavioral health market.